John R. Mascola

84.7k total citations · 8 hit papers
346 papers, 27.6k citations indexed

About

John R. Mascola is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, John R. Mascola has authored 346 papers receiving a total of 27.6k indexed citations (citations by other indexed papers that have themselves been cited), including 274 papers in Virology, 180 papers in Immunology and 136 papers in Infectious Diseases. Recurrent topics in John R. Mascola's work include HIV Research and Treatment (272 papers), Immune Cell Function and Interaction (143 papers) and HIV/AIDS drug development and treatment (85 papers). John R. Mascola is often cited by papers focused on HIV Research and Treatment (272 papers), Immune Cell Function and Interaction (143 papers) and HIV/AIDS drug development and treatment (85 papers). John R. Mascola collaborates with scholars based in United States, Sweden and United Kingdom. John R. Mascola's co-authors include Peter D. Kwong, Gary J. Nabel, David C. Montefiori, Richard T. Wyatt, Mark K. Louder, Barney S. Graham, Dennis R. Burton, Barton F. Haynes, Robert T. Bailer and Deborah L. Birx and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John R. Mascola

345 papers receiving 27.1k citations

Hit Papers

Protection of macaques ag... 1999 2026 2008 2017 2000 2005 2010 1999 2012 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
    2000 1000 citations John R. Mascola, Thomas C. VanCott et al. profile →
  2. Human Immunodeficiency Virus Type 1envClones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
    2005 845 citations John R. Mascola, Victoria R. Polonis et al. Journal of Virology profile →
  3. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
    2010 821 citations Tongqing Zhou, Ivelin S. Georgiev et al. Science profile →
  4. Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies
    1999 635 citations John R. Mascola, Mark G. Lewis et al. Journal of Virology profile →
  5. Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
    2012 619 citations Mark K. Louder, Nicole A. Doria‐Rose et al. profile →
  6. Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection
    2015 515 citations Srinivas S. Rao, Peter D. Kwong et al. profile →
  7. Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
    2009 446 citations Michael S. Seaman, Natalie Hawkins et al. Journal of Virology profile →
  8. Next-generation influenza vaccines: opportunities and challenges
    2020 234 citations John R. Mascola, Gary J. Nabel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Mascola United States 92 19.4k 13.2k 10.0k 7.0k 6.2k 346 27.6k
David C. Montefiori United States 92 25.7k 1.3× 17.2k 1.3× 11.1k 1.1× 8.1k 1.2× 8.9k 1.4× 616 33.7k
John P. Moore United States 110 30.2k 1.6× 16.8k 1.3× 14.1k 1.4× 10.0k 1.4× 6.0k 1.0× 384 37.5k
George M. Shaw United States 91 25.1k 1.3× 11.9k 0.9× 14.2k 1.4× 5.4k 0.8× 7.7k 1.2× 236 32.1k
Jeffrey D. Lifson United States 84 20.5k 1.1× 13.7k 1.0× 9.8k 1.0× 4.6k 0.7× 7.3k 1.2× 360 28.1k
Bette Korber United States 82 17.1k 0.9× 7.8k 0.6× 10.8k 1.1× 5.9k 0.8× 4.7k 0.8× 257 22.7k
Richard T. Wyatt United States 68 16.9k 0.9× 10.1k 0.8× 6.8k 0.7× 6.6k 0.9× 3.1k 0.5× 153 20.6k
Richard A. Koup United States 102 22.9k 1.2× 24.4k 1.8× 13.9k 1.4× 6.4k 0.9× 9.4k 1.5× 309 42.6k
Jaap Goudsmit Netherlands 85 11.5k 0.6× 6.1k 0.5× 11.1k 1.1× 5.1k 0.7× 7.1k 1.1× 329 23.6k
Gary J. Nabel United States 108 9.8k 0.5× 14.3k 1.1× 10.9k 1.1× 14.1k 2.0× 8.8k 1.4× 365 38.2k
Nathaniel R. Landau United States 57 14.7k 0.8× 10.0k 0.8× 7.4k 0.7× 6.2k 0.9× 4.4k 0.7× 116 21.5k

Countries citing papers authored by John R. Mascola

Since Specialization
Citations

This map shows the geographic impact of John R. Mascola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Mascola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Mascola more than expected).

Fields of papers citing papers by John R. Mascola

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Mascola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Mascola. The network helps show where John R. Mascola may publish in the future.

Co-authorship network of co-authors of John R. Mascola

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Mascola. A scholar is included among the top collaborators of John R. Mascola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Mascola. John R. Mascola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Galkin, Andrey, Javier Guenaga, Sijy O’Dell, et al.. (2020). HIV-1 gp120–CD4-Induced Antibody Complex Elicits CD4 Binding Site–Specific Antibody Response in Mice. The Journal of Immunology. 204(6). 1543–1561. 4 indexed citations
2.
Sutton, Matthew S., Amy Ellis, Alexis J. Balgeman, et al.. (2019). CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 93(15). 7 indexed citations
3.
Wagh, Kshitij, Michael S. Seaman, Dan H. Barouch, et al.. (2018). Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. PLoS Pathogens. 14(3). e1006860–e1006860. 57 indexed citations
4.
Crooks, Ema T., Samantha L. Grimley, Michelle D. Cully, et al.. (2018). Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation. PLoS Pathogens. 14(5). e1007024–e1007024. 19 indexed citations
5.
Jülg, Boris, Po-Ting Liu, Kshitij Wagh, et al.. (2017). Protection against a mixed SHIV challenge by a broadly neutralizing antibody cocktail. Science Translational Medicine. 9(408). 96 indexed citations
6.
Forsell, Mattias N.E., Krisha McKee, Yu Feng, John R. Mascola, & Richard T. Wyatt. (2014). HIV-1 Envelope Glycoprotein Trimer Immunogenicity Elicited in the Presence of Human CD4 Alters the Neutralization Profile. AIDS Research and Human Retroviruses. 30(11). 1089–1098. 5 indexed citations
7.
Kwon, Young Do, Andrés Finzi, Xueling Wu, et al.. (2012). Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops. Proceedings of the National Academy of Sciences. 109(15). 5663–5668. 197 indexed citations
8.
Gautam, Rajeev, Yoshiaki Nishimura, W. Robert Lee, et al.. (2012). Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIV AD8 in Rhesus Macaques: Implications for Use in Vaccine Studies. Journal of Virology. 86(16). 8516–8526. 35 indexed citations
9.
Li, Yuxing, Sijy O’Dell, Richard F. Wilson, et al.. (2012). HIV-1 Neutralizing Antibodies Display Dual Recognition of the Primary and Coreceptor Binding Sites and Preferential Binding to Fully Cleaved Envelope Glycoproteins. Journal of Virology. 86(20). 11231–11241. 48 indexed citations
10.
Zhou, Tongqing, Ivelin S. Georgiev, Xueling Wu, et al.. (2010). Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01. Science. 329(5993). 811–817. 821 indexed citations breakdown →
11.
Sundling, Christopher, Mattias N.E. Forsell, Sijy O’Dell, et al.. (2010). Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates. The Journal of Experimental Medicine. 207(9). 2003–2017. 80 indexed citations
12.
Wu, Xueling, Tongqing Zhou, Sijy O’Dell, et al.. (2009). Mechanism of Human Immunodeficiency Virus Type 1 Resistance to Monoclonal Antibody b12 That Effectively Targets the Site of CD4 Attachment. Journal of Virology. 83(21). 10892–10907. 77 indexed citations
13.
Sun, Yue, Robert T. Bailer, Srinivas S. Rao, et al.. (2009). Systemic and Mucosal T-Lymphocyte Activation Induced by Recombinant Adenovirus Vaccines in Rhesus Monkeys. Journal of Virology. 83(20). 10596–10604. 14 indexed citations
14.
Binley, James Μ., Emma T. Crooks, Michael S. Seaman, et al.. (2008). Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C. Journal of Virology. 82(23). 11651–11668. 278 indexed citations
15.
Mörner, Andreas, Iyadh Douagi, Mattias N.E. Forsell, et al.. (2008). Human Immunodeficiency Virus Type 1 Env Trimer Immunization of Macaques and Impact of Priming with Viral Vector or Stabilized Core Protein. Journal of Virology. 83(2). 540–551. 49 indexed citations
16.
Letvin, Norman L., John R. Mascola, Yue Sun, et al.. (2006). Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys. Science. 312(5779). 1530–1533. 287 indexed citations
17.
Ignatius, Ralf, Michael A. Eller, Kevin A. Wilkinson, et al.. (2004). Macaque Dendritic Cells Infected with SIV-Recombinant Canarypox ex Vivo Induce SIV-Specific Immune Responses in Vivo. AIDS Research and Human Retroviruses. 20(8). 871–884. 13 indexed citations
18.
Kim, Jérôme H., Punnee Pitisuttithum, Thippawan Chuenchitra, et al.. (2003). Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1. AIDS Research and Human Retroviruses. 19(9). 807–816. 19 indexed citations
19.
Brachtel, Elena F., John R. Mascola, Douglas J. Wear, et al.. (2002). Demonstration of de Novo HIV Type 1 Production by Detection of Multiply Spliced and Unspliced HIV Type 1 RNA in Paraffin-Embedded Tonsils. AIDS Research and Human Retroviruses. 18(11). 785–790. 5 indexed citations
20.
Mascola, John R., et al.. (1993). Summary Report: Workshop on the Potential Risks of Antibody-Dependent Enhancement in Human HIV Vaccine Trials. AIDS Research and Human Retroviruses. 9(12). 1175–1184. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David C. Montefiori Breakdown of academic impact, for papers by John P. Moore Breakdown of academic impact, for papers by George M. Shaw Breakdown of academic impact, for papers by Jeffrey D. Lifson Breakdown of academic impact, for papers by Bette Korber Breakdown of academic impact, for papers by Richard T. Wyatt Breakdown of academic impact, for papers by Richard A. Koup Breakdown of academic impact, for papers by Jaap Goudsmit Breakdown of academic impact, for papers by Gary J. Nabel Breakdown of academic impact, for papers by Nathaniel R. Landau
Rankless by CCL
2026